Homepage
Canterbury Scientific, the leading global OEM supplier of high quality, stable IVD Controls and Calibrators for diabetes and hemoglobinopathy assays.
canterburyscientific.comCrawled Oct 15, 2026
Canterbury Scientific, the leading global OEM supplier of high quality, stable IVD Controls and Calibrators for diabetes and hemoglobinopathy assays.
Canterbury Scientific's notice explains its policy for information recorded about website visitors and customers' representatives or beneficial owners, including conditions for processing personal and non-personal information.
Aptatek Biosciences secures financing to advance its **PheCheck™** clinical program, a **Breakthrough-designated** FDA product. The tool leverages the company’s **HomeCheck™ platform** for decentralized monitoring of metabolic conditions, enabling at-home diagnostics.
An in vitro diagnostics (IVD) manufacturer adopts an industry-specific Quality Management System (QMS) to simplify production workflows and enhance quality control. The system addresses challenges posed by operating across diverse regulatory environments. The solution integrates specialized tools tailored for IVD compliance and efficiency.
Aptatek BioSciences secures bridge financing from its existing strategic investor, Canterbury Scientific. The funding supports the company’s operational needs and development milestones as it advances its biotechnology projects.
Aptatek BioSciences secures bridge financing from Canterbury Scientific to develop its **PheCheck** aptamer-based in-home monitoring platform. The funding supports further advancement of the diagnostic tool, which enables decentralized health monitoring outside clinical settings. The company leverages aptamer technology for precise, portable disease tracking.
Aptatek BioSciences secures a new funding tranche following successful clinical trials of its **PheCheck** aptamer-based in-home monitoring platform. The platform targets phenylketonuria (PKU) management, enabling patients to track metabolic levels outside clinical settings. Investors include **Canterbury Scientific**, **LDT**, and the **National PKU Alliance**, reflecting confidence in the technology’s potential for decentralized diagnostics.